Related Experiment Videos
The proteasome in cancer biology and treatment
1Department of Radiation Therapy, Radiological University Clinic, Hugstetter Str. 55, 79106 Freiburg i. Brsg., Germany. pajonk@uni-freiburg.de
Abstract:
During the last 30 years, investigation of the transcriptional and translational mechanisms of gene regulation has been a major focus of molecular cancer biology. More recently, it has become evident that cancer-related mutations and cancer-related therapies also can affect post-translational processing of cellular proteins and that control exerted at this level can be critical in defining both the cancer phenotype and the response to therapeutic intervention. One post-translational mechanism that is receiving considerable attention is degradation of intracellular proteins through the multicatalytic 26S proteasome. This follows growing recognition of the fact that protein degradation is a well-regulated and selective process that can differentially control intracellular protein expression levels. The proteasome is responsible for the degradation of all short-lived proteins and 70-90% of all long-lived proteins, thereby regulating signal transduction through pathways involving factors such as AP1 and NFKB, and processes such as cell cycle progression and arrest, DNA transcription, DNA repair/misrepair, angiogenesis, apoptosis/survival, growth and development, and inflammation and immunity, as well as muscle wasting (e.g. in cachexia and sepsis). In this review, we discuss the potential involvement of the proteasome in both cancer biology and cancer treatment.
Insights
The 26S proteasome, a key protein degradation system, plays a critical role in regulating cellular processes relevant to cancer biology and treatment. Understanding its function is vital for developing new cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- Gene regulation research has historically focused on transcriptional and translational mechanisms.
- Emerging evidence highlights the significance of post-translational protein modifications in cancer development and therapy response.
- Protein degradation via the 26S proteasome is a critical, regulated process influencing numerous cellular functions.
Purpose of the Study:
- To review the involvement of the 26S proteasome in cancer biology.
- To discuss the role of the 26S proteasome in cancer treatment strategies.
Main Methods:
- Literature review focusing on proteasome function in cancer.
- Analysis of proteasome's role in regulating key cellular processes relevant to cancer.
- Examination of proteasome's impact on cancer-related mutations and therapies.
Main Results:
- The 26S proteasome regulates diverse cellular processes including signal transduction, cell cycle, DNA repair, angiogenesis, apoptosis, and inflammation.
- Dysregulation of proteasome activity is implicated in cancer development and progression.
- The proteasome is a validated target for cancer therapy, with several drugs already in clinical use.
Conclusions:
- The 26S proteasome is a crucial regulator of cellular homeostasis and a significant player in cancer biology.
- Targeting the proteasome offers a promising therapeutic avenue for various cancers.
- Further research into proteasome mechanisms can lead to improved cancer treatment strategies.